Thessaloniki

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Myeloproliferative neoplasms

Running trials

• Active, not recruiting

  A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)

  NCT04817007· Phase 1/2· Bristol-Myers Squibb· Source